Related Experiment Video
Updated: Aug 15, 2026

LERLIC-MS/MS for In-depth Characterization and Quantification of Glutamine and Asparagine Deamidation in Shotgun Proteomics
Published on: April 9, 2017
Deamidation: a source of microheterogeneity in pharmaceutical proteins
1Division of Biochemistry and Biophysics, Food and Drug Administration, Bethesda, MD 20892.
Protein deamidation occurs naturally and during pharmaceutical manufacturing. This process creates microheterogeneity, impacting drug quality and requiring attention from manufacturers and regulatory agencies.
Area of Science:
- Biochemistry
- Pharmaceutical Science
- Protein Chemistry
Background:
- Spontaneous deamidation is a common post-translational modification in proteins in vivo.
- Deamidation can also occur during pharmaceutical protein production, purification, formulation, and storage.
- This process contributes to protein microheterogeneity, affecting drug product quality.
Purpose of the Study:
- To provide an overview of the scientific and regulatory considerations of protein deamidation.
- To highlight the significance of deamidation as a source of microheterogeneity in pharmaceutical proteins.
- To emphasize the need for addressing deamidation by both manufacturers and regulatory bodies.
Main Methods:
- Literature review of scientific data on protein deamidation.
- Analysis of regulatory guidelines and concerns related to protein modifications.
- Synthesis of information on the impact of deamidation on pharmaceutical protein quality.
Main Results:
- Deamidation is an inherent process affecting protein integrity.
- Microheterogeneity arising from deamidation poses challenges for pharmaceutical product consistency.
- Both scientific understanding and regulatory oversight are crucial for managing deamidation.
Conclusions:
- Deamidation is a critical factor in pharmaceutical protein stability and quality.
- Addressing deamidation requires a collaborative approach between industry and regulatory agencies.
- Further research and standardized methods are needed to control and monitor deamidation.
More Related Videos
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
11:32A Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) Platform for Investigating Peptide Biosynthetic Enzymes
Published on: May 4, 2020
Related Concept Videos
Protein Folding
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA molecules by RNA...
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Denaturation
Amino Acid Catabolism